VCM
AGN

Voleon Capital Management’s Allergan plc AGN Stock Holding History

Voleon Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-132,000
Closed -$25.2M – 165
2019
Q4 		$25.2M Sell
132,000
-316,000
-71% -$57M 1.46% 16
2019
Q3 		$75.4M Buy
+448,000
New +$73M 5.81% 3

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Voleon Capital Management's AGN Position: Q1 2020 in Review

Voleon Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 132,000 shares — an estimated $25.2M sold.

Voleon Capital Management first reported a position in AGN in Q3 2019 and held it in 2 quarters. The position peaked at $75.4M in Q3 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Voleon Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Voleon Capital Management sold 132,000 Allergan plc shares in Q1 2020, an estimated $25.2M.
  • Voleon Capital Management first reported a position in Allergan plc in Q3 2019 and held it in 2 quarters.
  • Voleon Capital Management's Allergan plc position peaked at $75.4M in Q3 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Voleon Capital Management's 13F filing for Q1 2020.